Clinical Protocols < Clinical Trials as Topic < Clinical Trials as Topic (ethics)

Facettes :

List of bibliographic references indexed by Clinical Trials as Topic

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]

Ident.	Authors (with country if any)	Title
000544 (2015)	Soania Mathur [Canada] ; Steve Dewitte [Royaume-Uni] ; Israel Robledo [Royaume-Uni] ; Tom Isaacs [Royaume-Uni] ; Jon Stamford [Royaume-Uni]	Rising to the Challenges of Clinical Trial Improvement in Parkinson's Disease.
000608 (2015)	Marie-Laure Welter [France] ; David Grabli [France] ; Carine Karachi [France] ; Nicolas Jodoin [France] ; Sara Fernandez-Vidal [France] ; Yohann Brun [France] ; Soledad Navarro [France] ; Alister Rogers [France] ; Philippe Cornu [France] ; Bernard Pidoux [France] ; Jérôme Yelnik [France] ; Emmanuel Roze [France] ; Eric Bardinet [France] ; Marie Vidailhet [France]	Pallidal activity in myoclonus dystonia correlates with motor signs.
000764 (2015)	Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Anthony E. Lang [Canada]	Disease-modifying strategies for Parkinson's disease.
000887 (2014)	Jamie Eberling [États-Unis] ; Lona Vincent [États-Unis] ; Jennifer G. Goldman ; Daniel Weintraub ; Jaime Kulisevsky ; Connie Marras ; Glenn Stebbins ; Karl Kieburtz	Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory Roundtable
000890 (2014)	Leonardo Cortez ; Valerie Sim	The therapeutic potential of chemical chaperones in protein folding diseases
000922 (2014)	Tiago A. Mestre [Canada] ; Alberto J. Espay ; Connie Marras ; Mark H. Eckman ; Pierre Pollak ; Anthony E. Lang	Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better.
000937 (2014)	Donald A. Mcafee [Canada] ; Jonathan Hadgraft [Royaume-Uni] ; Majella E. Lane [Royaume-Uni]	Rotigotine: the first new chemical entity for transdermal drug delivery.
001142 (2012)	Sheridan M. Hoy [Nouvelle-Zélande] ; Gillian M. Keating	Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease.
001632 (2011)	Marco Onofrj [Italie] ; Astrid Thomas	Movement disorders in focus: experts debate on pathophysiology and concomitant signs.
001898 (2011)	Anthony E. Lang [Canada]	A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials
001980 (2010)	Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer ; Edwin Mak ; Vesna Sossi	Trials of neuroprotective therapies for Parkinson's disease: problems and limitations.
001A84 (2010)	Michael G. Schlossmacher [Canada] ; Brit Mollenhauer	Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.
002158 (2008)	Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. Brotchie	Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
002190 (2008)	Murray Hong [Canada] ; Karim Mukhida ; Ivar Mendez	GDNF therapy for Parkinson's disease.
002457 (2007)	Joseph S. Tauskela [Canada]	MitoQ--a mitochondria-targeted antioxidant.
002718 (2006)	V. Voon [États-Unis] ; K. Hassan ; M. Zurowski ; M. De Souza ; T. Thomsen ; S. Fox ; A E Lang ; J. Miyasaki	Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.
002729 (2006)	Joseph S. Neimat [Canada] ; Clement Hamani ; Andres M. Lozano	Neural stimulation for Parkinson's disease: current therapies and future directions.
002930 (2006)	Charles Ramassamy [Canada]	Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases : A review of their intracellular targets
002950 (2005)	Donald Calne [Canada] ; Michael Schulzer ; Edwin Mak ; A Jon Stoessl	Treatment for the progression of Parkinson's disease.
002A01 (2005)	Tom H. Johnston [Canada] ; Susan H. Fox ; Jonathan M. Brotchie	Advances in the delivery of treatments for Parkinson's disease.
002B69 (2004)	Connie Marras [Canada] ; Antony E. Lang	Outcome measures for clinical trials in Parkinson's disease: achievements and shortcomings.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Clinical Trials as Topic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Clinical Trials as Topic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Clinical Trials as Topic
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022